The FDA puts its highest-risk label on a recall of LeMaitre Vascular's Albograft vascular graft. The FDA put its highest-risk Class I label on a recall issued by LeMaitre Vascular (NSDQ:LMAT) over leakage concerns for the Albograft vascular grafts. The affected devices, manufactured in April 2011 and distributed through June 2013, were only distributed in Pennsylvania, according to the FDA notice.